BCAB (STOCKS)
BioAtla, Inc. Common Stock
$0.174400
-0.026300 (-13.10%)
Prev close: $0.200700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jay M. Short
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.66M
- Employees
- 61
- P/E (TTM)
- -0.16
- P/B (TTM)
- -0.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.27 | $-0.30 | +0.0326 | +10.77% |
|
Jun 2025 (Q2)
|
$-0.32 | $-0.34 | +0.0243 | +7.06% |
|
Mar 2025 (Q1)
|
$-0.26 | $-0.35 | +0.0936 | +26.47% |
|
Dec 2024 (Q4)
|
$-0.30 | $-0.39 | +0.0876 | +22.60% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $66.29M |
| Research and Development | $47.23M |
| Other Operating Expenses | $19.07M |
| Operating Income/Loss | -$66.29M |
| Income/Loss From Continuing Operations After Tax | -$64.71M |
| Income/Loss From Continuing Operations Before Tax | -$64.71M |
| Net Income/Loss | -$64.71M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$64.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$64.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.15 |
| Diluted Earnings Per Share | -$1.15 |
| Basic Average Shares | 58,861,653 |
| Diluted Average Shares | 58,861,653 |
| Assets | $15.91M |
| Current Assets | $9.67M |
| Noncurrent Assets | $6.24M |
| Fixed Assets | $324.00K |
| Other Non-current Assets | $5.91M |
| Liabilities | $47.15M |
| Current Liabilities | $17.98M |
| Accounts Payable | $5.85M |
| Other Current Liabilities | $12.13M |
| Noncurrent Liabilities | $29.16M |
| Equity | -$31.24M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$31.24M |
| Liabilities And Equity | $15.91M |
| Net Cash Flow From Operating Activities | -$57.07M |
| Net Cash Flow From Operating Activities, Continuing | -$57.07M |
| Net Cash Flow From Investing Activities | $48.20M |
| Net Cash Flow From Investing Activities, Continuing | $48.20M |
| Net Cash Flow From Financing Activities | $8.88M |
| Net Cash Flow From Financing Activities, Continuing | $8.88M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$64.71M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$64.71M |
| Other Comprehensive Income/Loss | $0.00 |